Article Details

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Retrieved on: 2021-03-01 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics. View article details on hiswai:

Excerpt

NovaBiotics Ltd, the clinical-stage anti-infectives biotechnology company, ... NP432, derived from NovaBiotics' antimicrobial peptide platform, is a ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo